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Among 4380 children born in 1987–1997 of women with a diagnosis of diabetes and alive at the age of one, 10 were
registered in the Swedish Cancer Registry before the end of 1998. The odds ratio for having a childhood cancer after maternal
diabetes, stratiﬁed for year of birth, maternal age, parity, multiple birth, and 500 g birth weight class was 2.25 (95%CI 1.22–
4.15). Among 5842 children born during the period 1973–1997 whose mothers had other auto-immune diseases (SLE,
rheumatoid arthritis, Crohn, ulcerous colitis, multiple sclerosis or thyroiditis), the number of observed childhood cancers (9)
was close to that expected (8.5). Maternal diabetes but not other auto-immune diseases may be a risk factor for childhood
cancer.
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A few epidemiological studies have suggested that children whose
families suffer from auto-immune disease including juvenile diabetes
have an increased risk of haematopoietic malignancies (Till et al,
1979; Woods et al, 1987; Buckley et al, 1989). A Danish study
(Mellemkjaer et al, 2000) revealed a moderately increased risk for
childhood lymphomas and leukaemia of borderline statistical signiﬁ-
cance, while a positive association between childhood leukaemia and
maternal diabetes was reported from Greece (Petridou et al, 1997).
Also, an increased risk of hospitalisation for childhood neoplasia
was reported when the mother had diabetes before the pregnancy
(odds ratio 1.64, 95%CI 1.06–2.54) but not when she had gesta-
tional diabetes (A ˚berg and Westbom, 2001).
Using the Swedish Cancer Registry we have examined the occur-
rence of cancer in children whose mothers had diabetes or other
auto-immune diseases before the pregnancy, utilising the Swedish
Registry of Cancer with a high diagnostic accuracy.
MATERIALS AND METHODS
The study is based on a record linkage between two large and coun-
try-wide health registers in Sweden: the Medical Birth Registry and
the Cancer Registry. The former contains medical information on
practically all births in Sweden (1–2% are missing) and is based
on copies of medical records from the antenatal care clinics, delivery
units, and the paediatric examinations of the newborns (Cnattingius
et al, 1990). Maternal diagnoses are given as ICD codes and women
with diabetes can (since 1987) be identiﬁed from ICD code
ICD9648.0, ICD10 O24.0). Other auto-immune diseases could be
studied from maternal diagnoses for the whole period 1973–1997:
systemic lupus erythematosus (SLE), rheumatic arthritis (RA), scler-
oderma, Crohn’s disease or ulcerative colitis (inﬂammatory bowel
disease, IBD), multiple sclerosis (MS), and thyroiditis.
The Cancer Registry receives reports from physicians treating
cancer patients and pathology and cytology departments, including
autopsy ﬁndings. The overall reporting is estimated to be close to
99% (The National Board of Health, Stockholm, 1995) but lower
registration rates may exist for speciﬁc types of cancer.
Linkage between the two registers was made using the unique
identiﬁcation numbers each person in Sweden receives and which
is extensively used, including by all health care facilities.
In the study of maternal diabetes, births for the period 1987-
1997 were followed in the Cancer Registry up to and including
1998. Four sets of data were identiﬁed: (i) all children born in
these years with a diagnosis of childhood cancer; (ii) all children
born to mothers with a diagnosis of diabetes and identiﬁed in
the Cancer Registry; (iii) all children alive at the age of one born
to mothers with a diagnosis of diabetes; and (iv) all children in
the population alive at the age of one. The restriction to children
alive at the age of one was made in order to compensate for the
slightly higher infant death rate associated with maternal diabetes.
The risk for developing cancer in children whose mothers had
diabetes was estimated as an odds ratio (OR), using Mantel–
Haenszel procedure and stratifying for year of birth, maternal age
(5 year classes), parity (1–4+), and sometimes also birth weight
(500 g classes). Conﬁdence intervals were determined using Mietti-
nen’s test based method (95%CI).
The effect of birth weight on cancer risk was also examined irre-
spective of maternal diabetes. A corresponding analysis for other
maternal auto-immune diseases was made for the whole period
1973–1997.
RESULTS
The data comprised details of 4380 children born of women with a
diagnosis of diabetes and alive at the age of 1 year among 1285100
such children in the population, a prevalence of 3.4 per 1000.
E
p
i
d
e
m
i
o
l
o
g
y
Received 2 October 2001; revised 14 December 2001; accepted 21
January 2002
*Correspondence: Professor B Ka ¨lle ￿n; E-mail: embryol@embryol.lu.se.
British Journal of Cancer (2002) 86, 1078–1080
ã 2002 Cancer Research UK All rights reserved 0007–0920/02 $25.00
www.bjcancer.comWe also identiﬁed 5842 children born to women with another
auto-immune disease: 1505 with SLE or RA, 120 with scleroderma,
3945 with IBD, 102 with MS, and 122 with thyroiditis. A further 47
mothers had combinations of these diseases. The annual rate of
identiﬁed cases varied markedly due to different ascertainment
methods and use of different ICD classiﬁcation systems. For the
period 1973–1981, the mean annual number of cases was only
16, for the period 1982–1990 it was 135, and for the period
1991–1997 it was 639.
The total number of children, born in 1987–1997, registered in
the Cancer Registry with a malignancy up to the end of 1998 and
present also in the Medical Birth Registry, was 1419 (1.1 per
1000).
There were 10 children with cancer born of mothers with
diabetes. Table 1 lists these children with their cancers speciﬁed
and their birth weight. Except for the last case, all children were
at least 1-year-old at the cancer diagnosis. None of the 10 chil-
dren was known to be diabetic. We checked the type of
diabetes in the mothers of the 10 children with cancer: all had
type 1 diabetes.
The expected number (irrespective of year of birth) of cancers
among the children born to diabetic mothers is 4.8. Because of
different follow-up times a stratiﬁcation is required for year of
birth resulting in an OR=2.19 (95%CI 1.19–4.02). If stratiﬁcation
is made also for maternal age, parity and multiple birth, the OR
increases slightly to 2.38 (95%CI 2.15–2.62).
The impact of birth weight on cancer risk is shown in Table 2.
There is a statistically signiﬁcant excess risk at very low birth
weight (52 kg) and a slight and statistically not signiﬁcant
increased risk at birth weight over 4.5 kg. The OR for childhood
cancer given maternal diabetes, stratiﬁed for year of birth, maternal
age, parity, multiple birth and 500 g birth weight class is 2.25
(95%CI 1.22–4.15). All 10 cancers were diagnosed before 4 years
age. When the analysis is restricted to cancer diagnosed below
age 4, the OR is 2.83 (95%CI 1.56–5.17) and when restricted to
below age 2, the OR is 3.56 (95%CI 1.84–6.90).
Among the 10 infants with childhood cancer, seven were female,
a sex ratio of 0.43 (exact 95%CI 0.07–1.87), thus not signiﬁcantly
different from the normal ratio of 1.06.
We identiﬁed nine instances of cancer among children born to
women with other auto-immune diseases (Table 3) compared to
8.5, stratiﬁed for year of birth. It is of interest that there was no
case of acute lymphatic leukaemia and that eight of the nine
cancers were non-haematopoietic.
DISCUSSION
The study was performed to explore an unexpected ﬁnding in a
previous study, an increased hospitalisation rate due to neoplasms
in children to mothers with diabetes mellitus before the relevant
pregnancy (A ˚berg and Westbom, 2001).
The present paper is based on data from the national health
registers in Sweden. It is to be expected that some cases of maternal
diabetes are missed and also some cases of childhood cancer. The
total rate of maternal diabetes observed (3.4 per 1000), however,
agrees with the expected rate. Data loss must be non-differential
as loss of information on maternal diabetes cannot be inﬂuenced
by later childhood cancer and loss of cancer cases can hardly be
affected by the presence of maternal diabetes. Such losses will
therefore have very little effect on the risk estimates.
This study ﬁnds an increased risk of cancer among children
whose mother had insulin dependent diabetes before the relevant
pregnancy. This was apparently not an effect of macrosomia at
birth. An increased risk of childhood cancer with high birth weight
has been reported (Daling et al, 1984; Greenberg et al, 1985; Kaye
et al, 1991; Petridou et al, 1997) and was also present in our ma-
terial, though stratiﬁcation for birth weight did not remove the
statistically signiﬁcant increase in OR. The observed increased risk
at low birth weight was also found by Forsberg and Ka ¨lle ￿n (1990).
We found no association between childhood cancer and mater-
nal auto-immune diseases other than diabetes which weighs against
a mechanism based on auto-immunity. A previously reported asso-
ciation between parental auto-immune disease and childhood
cancer was mainly based on paternal diabetes (Mellemkjaer et al,
2000).
The risk increase seen with maternal diabetes amounts to about
a doubling and is thus still very small. The contribution to child-
hood cancer in the population is also small due to the relatively
low number of diabetic pregnancies. If one in 300 infants born
have a mother with diabetes, this means that the total childhood
cancer rate increases by 0.3%, about one case in each Swedish birth
cohort (of approximately 100000 births). It is possible that genetic
factors are signiﬁcant for the development both of cancer and of
diabetes.
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Table 1 Summary of children with cancer and born to women with
diabetes existing before pregnancy
Year of Age at Infant Birth
birth diagnosis sex Cancer type weight (g)
1989 3 years 5 months f Kidney cancer 3530
1991 1 year 11 months f ALL 3700
1991 3 years 5 months f ALL 3800
1992 2 years 4 months f Sarcoma, pelvis 2520
1993 1 year 7 months f ALL 4370
1993 2 years 11 months f Kidney cancer 4250
1994 2 years 5 months m ALL 2905
1995 2 years 9 months m CML 3470
1996 1 year 2 months f Retinoblastoma 4305
1997 0 years 1 month m Bladder cancer 2560
ALL=acute lymphoblastic leukaemia. CML=chronic myeloid leukaemia.
Table 2 Infant birth weight and childhood cancer risk
Birth weight class Number OR 95% CI
–1999 38 1.63 1.18–2.26
2000–2999 204 0.93 0.79–1.07
3000–3999 1056 1.00 reference
4000–4499 224 0.93 0.80–1.08
4500– 64 1.19 0.93–1.54
Odds ratios (OR) with 95% conﬁdence intervals (95% CI) stratiﬁed for year of birth,
maternal age, and parity.
Table 3 Details of children with cancer born to women with
auto-immune diseases other than diabetes existing before pregnancy
Year of Age at Infant Maternal
birth diagnosis sex Cancer type disease
1989 2 years 10 months f Retinal cancer SLE/RA
1992 6 years 5 months f Kidney cancer IBD
1992 4 years 2 months f Sarcoma IBD
1993 2 years 8 months m Brain cancer IBD
1994 2 years 0 months f Sarcoma IBD
1995 1 year 8 months f Brain cancer IBD
1995 0 years 4 months m Non-Hodgkin lymphoma SLE/RA
1996 2 years 0 months m Sarcoma SLE/RA
1996 0 years 3 months f Unspec. peritoneal IBD
IBD=inﬂammatory bowel disease; RA=rheumatic arthritis; SLE=systemic lupus
erythematosus.
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